Healing & Recovery

BPC-157

Body Protection Compound — a 15-amino acid peptide with remarkable regenerative and healing properties.

C62H98N16O22Half-life: 4 hours (systemic), locally longerMolar mass: 1419.56 g/mol

⚠ Research & Educational Use Only. BPC-157 is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Medically reviewed by Dr. Amanda Reid, MDWritten by the KnowYourPeptide Research TeamLast updated April 2026
Our editorial standards →
Key Takeaways
  • Accelerates healing of tendons, ligaments, and muscle tissue
  • Reduces inflammation and pain at injury sites
  • Heals gut lining — effective for IBD, leaky gut, and ulcers
  • BPC-157 is not FDA-approved for human use. It is a research chemical for scientific study only.

Research At a Glance

  • Accelerates healing of tendons, ligaments, and muscle tissue
  • Reduces inflammation and pain at injury sites
  • Heals gut lining — effective for IBD, leaky gut, and ulcers
  • Promotes angiogenesis (new blood vessel formation)
Calculate BPC-157 dose

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a pentadecapeptide composed of 15 amino acids, originally derived from a protective protein found in human gastric juice. It has been extensively studied for its extraordinary healing and regenerative effects across a wide range of tissues including tendons, ligaments, muscles, the gut lining, and the nervous system. BPC-157 is thought to work primarily by upregulating growth hormone receptors and modulating nitric oxide production, promoting angiogenesis (new blood vessel formation) and accelerating tissue repair. Research has consistently shown it to be safe and non-toxic with no known LD50.

Key Research Benefits

Documented effects observed in preclinical and clinical studies on BPC-157. See all Healing & Recovery peptides for comparison.

Accelerates healing of tendons, ligaments, and muscle tissue
Reduces inflammation and pain at injury sites
Heals gut lining — effective for IBD, leaky gut, and ulcers
Promotes angiogenesis (new blood vessel formation)
Neuroprotective properties — supports nerve healing
May counteract the effects of NSAIDs and alcohol on the gut
Anti-ulcer properties — protects the gastric mucosa
Improves joint mobility and flexibility

Common Stacks

BPC-157 is frequently combined with the following peptides for synergistic effects. Click any peptide to compare profiles before deciding.

The most popular healing stack - BPC-157 handles acute repair while TB-500 promotes systemic tissue remodeling and angiogenesis.

TB-500 profile

BPC-157 drives mucosal healing while KPV directly suppresses NF-kB inflammation - together they cover both healing and anti-inflammatory dimensions of gut repair.

KPV profile

Often added to support GH-driven recovery, as Ipamorelin amplifies the regenerative signaling BPC-157 initiates.

Ipamorelin profile

KPV's anti-cytokine action pairs with BPC-157's angiogenic healing for a comprehensive gut and systemic inflammation protocol.

KPV profile

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.

Generally well-tolerated with minimal side effects reported in research
Mild nausea at higher doses
Potential for dizziness or lightheadedness
Injection site reactions (redness, irritation) with subcutaneous administration
Theoretical concern about promoting angiogenesis in existing tumors (unconfirmed in research)

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

Typical research dosing: 250–500 mcg per day. For systemic effects, subcutaneous or intramuscular injection is preferred. For localized healing (e.g., tendon), injecting near the injury site is recommended. Oral administration (500–1000 mcg) can be effective for gut-related issues.

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

BPC-157 is typically reconstituted with bacteriostatic water and administered via subcutaneous injection. For localized injuries, inject as close to the injury site as possible (proximal injection). For systemic or gut effects, subcutaneous injection in the abdomen is preferred. Some protocols use oral administration for gut healing. Cycle on for 4–6 weeks, then take a break of equal length.

Research Video

Explore Further

Quick Reference

Half-Life
4 hours (systemic), locally longer
Molar Mass
1419.56 g/mol
Formula
C62H98N16O22
Legal Status
Research chemical — not approved by the FDA for human use. Legal to purchase for research purposes in most countries.
Storage
Store lyophilized (freeze-dried) peptide at 2–8°C (refrigerator). Once reconstituted with bacteriostatic water, store at 2–8°C and use within 28–30 days. Avoid repeated freeze-thaw cycles.

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.